These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20397876)

  • 1. Near-death states reported in a sample of 50 misusers.
    Corazza O; Schifano F
    Subst Use Misuse; 2010 May; 45(6):916-24. PubMed ID: 20397876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of near-death experiences on dialysis patients: a multicenter collaborative study.
    Lai CF; Kao TW; Wu MS; Chiang SS; Chang CH; Lu CS; Yang CS; Yang CC; Chang HW; Lin SL; Chang CJ; Chen PY; Wu KD; Tsai TJ; Chen WY
    Am J Kidney Dis; 2007 Jul; 50(1):124-32, 132.e1-2. PubMed ID: 17591532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the psychological effects of ketamine: from euphoria to the k-Hole.
    Stirling J; McCoy L
    Subst Use Misuse; 2010 Dec; 45(14):2428-43. PubMed ID: 21039109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls.
    Morgan CJ; Muetzelfeldt L; Curran HV
    Addiction; 2009 Jan; 104(1):77-87. PubMed ID: 19133891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug.
    Morgan CJ; Monaghan L; Curran HV
    Addiction; 2004 Nov; 99(11):1450-61. PubMed ID: 15500598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Rasch scaling validation of a 'core' near-death experience.
    Lange R; Greyson B; Houran J
    Br J Psychol; 2004 May; 95(Pt 2):161-77. PubMed ID: 15142300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
    Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
    Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Journey through the K-hole: phenomenological aspects of ketamine use.
    Muetzelfeldt L; Kamboj SK; Rees H; Taylor J; Morgan CJ; Curran HV
    Drug Alcohol Depend; 2008 Jun; 95(3):219-29. PubMed ID: 18355990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of simultaneous polysubstance use in Canadian rave attendees.
    Barrett SP; Gross SR; Garand I; Pihl RO
    Subst Use Misuse; 2005; 40(9-10):1525-37. PubMed ID: 16048831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine as a primary predictor of out-of-body experiences associated with multiple substance use.
    Wilkins LK; Girard TA; Cheyne JA
    Conscious Cogn; 2011 Sep; 20(3):943-50. PubMed ID: 21324714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.
    Morgan CJ; Muetzelfeldt L; Curran HV
    Addiction; 2010 Jan; 105(1):121-33. PubMed ID: 19919593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consistency of near-death experience accounts over two decades: are reports embellished over time?
    Greyson B
    Resuscitation; 2007 Jun; 73(3):407-11. PubMed ID: 17289247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent trends in the use of "club drugs": an Australian review.
    Degenhardt L; Copeland J; Dillon P
    Subst Use Misuse; 2005; 40(9-10):1241-56. PubMed ID: 16048815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K; Turner JJ; Parrott AC
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of GHB and ketamine use in an Australian household survey.
    Degenhardt L; Dunn M
    Int J Drug Policy; 2008 Aug; 19(4):311-6. PubMed ID: 17920826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the arousal system contribute to near death experience?
    Nelson KR; Mattingly M; Lee SA; Schmitt FA
    Neurology; 2006 Apr; 66(7):1003-9. PubMed ID: 16606911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attentional bias to incentive stimuli in frequent ketamine users.
    Morgan CJ; Rees H; Curran HV
    Psychol Med; 2008 Sep; 38(9):1331-40. PubMed ID: 18177527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recreational ketamine: from pleasure to pain.
    Wood D; Cottrell A; Baker SC; Southgate J; Harris M; Fulford S; Woodhouse C; Gillatt D
    BJU Int; 2011 Jun; 107(12):1881-4. PubMed ID: 21314885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.